Exogenous testosterone: a preventable cause of male infertility.

Transl Androl Urol

1 University of Tennessee Graduate School of Medicine, Knoxville, TN, USA ; 2 University of Toronto, Toronto, CA, Canada ; 3 University of Michigan, Ann Arbor, MI, USA.

Published: June 2013

Main Problem: Testosterone replacement therapy inhibits spermatogenesis, representing a problem for hypogonadal men of reproductive age.

Methods: A literature review of PubMed from 1990-2013. Semen analysis and pregnancy outcomes, time to recovery of spermatogenesis, serum and intratesticular testosterone levels were examined.

Results: Exogenous testosterone suppresses intratesticular testosterone production, which is an absolute prerequisite for normal spermatogenesis. Therapies that protect the testis involve human chorionic gonadotropin (hCG) therapy or selective estrogen receptor modulators (SERMs), but may also include low dose hCG with exogenous testosterone. SERMs, such as clomiphene citrate, are effective for maintaining testosterone production and represent a well-tolerated, oral therapy. Routine use of aromatase inhibitors is not recommended based on a lack of long-term data.

Conclusions: Exogenous testosterone supplementation decreases sperm production. Studies of hormonal contraception indicate that most men have a return of normal sperm production within 1 year after discontinuation. Clomiphene citrate is a safe and effective therapy for men who desire to maintain future potential fertility. Although less frequently used in the general population, hCG therapy with or without testosterone supplementation represents an alternative treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708215PMC
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.06.01DOI Listing

Publication Analysis

Top Keywords

exogenous testosterone
16
testosterone
8
intratesticular testosterone
8
testosterone production
8
hcg therapy
8
clomiphene citrate
8
testosterone supplementation
8
sperm production
8
therapy
5
exogenous
4

Similar Publications

The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.

Reprod Biol Endocrinol

January 2025

Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.

The production of spermatozoa, a process known as spermatogenesis, is primarily controlled by follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-driven testosterone. LH acts on the Leydig cells, stimulating steroid production, predominantly testosterone, and activating critical inter-related spermatogenesis regulatory pathways. Despite evidence that exogenous gonadotropins containing LH activity can effectively restore spermatogenesis in males with hypogonadotropic hypogonadism, the use of these drugs to treat other forms of male infertility is the subject of an ongoing debate.

View Article and Find Full Text PDF

Testosterone Replacement Therapy Is Associated With Increased Incidence Rate of Vertebral Fractures: A Matched Retrospective Analysis.

J Am Acad Orthop Surg Glob Res Rev

January 2025

From the Warren Alpert Medical School, Brown University, Providence, RI (Singh and Daher), and the Department of Orthopedics, Brown University, Providence, RI (Dr. Diebo, Dr. Daniels, and Dr. Arcand).

Background: Whether testosterone replacement therapy (TRT) can mitigate the risk of vertebral fractures has not been well-studied.

Methods: PearlDiver was queried to identify patients with and without the history of TRT. Groups were matched 1:1 by demographic variables and 2-year vertebral fracture incidence rate was compared.

View Article and Find Full Text PDF

Context: 47,XXY/Klinefelter syndrome (XXY) is associated with impaired testicular function and differences in physical growth, metabolism, and neurodevelopment. Clinical features of XXY may be attributable to inadequate testosterone during the mini-puberty period of infancy.

Objective: We tested the hypothesis that exogenous testosterone treatment positively effects short-term physical, hormonal, and neurodevelopmental outcomes in infants with XXY.

View Article and Find Full Text PDF

Background: Transgender and gender diverse (TGD) people embody social and health inequalities that disproportionately affect this community more than the cisgender population. Endometriosis is a chronic condition of the reproductive tract that affects 5-10% of cisgender women. A recent systematic review with meta-analysis uncovered a pooled prevalence of 25.

View Article and Find Full Text PDF
Article Synopsis
  • Testosterone replacement therapy (TRT) usage has significantly increased in the U.S., but there is limited information on its link to ligament injuries, particularly ACL injuries.
  • This study aimed to determine the relationship between TRT and the occurrence of ACL injuries, along with the risk of ACL reconstruction failure, hypothesizing that TRT users would face higher risks for these injuries.
  • Results showed that TRT patients had a greater likelihood of sustaining ACL tears within the first two years, but there was no significant difference in ACL reconstruction failure rates between TRT users and non-users over a five-year period.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!